Compounding possibilities: Specialized compounding pharmacies could theoretically create peptide eye drops though stability and sterility challenging
Sipuleucel-T (Provenge())-Autopsy of an innovative paradigm change in cancer treatment: why a single-product biotech company failed to capitalize on its breakthrough invention
DSIP is a nine-residue naturally occurring peptide studied in sleep-related neuroregulatory research
The distinction between removing a brake and pressing the accelerator is important in terms of risk profile
2024, article 102920, Tchang, Beverly, et al
Why It Pairs So Well With GLP-1 Agonists GLP-1 agonists like Retatrutide create a caloric deficit through multiple routes: appetite suppression, slowed gastric emptying, and (in Reta's case) glucagon receptor agonism that drives additional energy expenditure